Latest News
Evergreen International Phage Biology Meeting 2019
Evergreen International Phage Biology Meeting 2019 JAFRAL is going to be again present at traditional Evergreen International Phage Biology Meeting US. You are welcome to meet [...]
Baceriophage Therapy Summit 2019
JAFRAL is proud to be sponsoring Bacteriophage Therapy Summit that will be held 25-27th of March 2019 in Boston, US.
The Phage Futures Congress 2019
JAFRAL is going to attend The Phage Futures 2019 in Washington, US. You are welcome to meet with our representative at the conference dr. Frenk Smrekar [...]
Gene therapy IL-12 clinical trial
JAFRAL is proud to be a GMP manufacturing partner of a consortium/project for first clinical trial on combined electrochemotherapy with gene therapy with Interleukin-12 (IL-12) to improve/enhance local and systemic response to skin tumor treatment.
Competence Center Bio-Pharm
As of June 1 2018 JAFRAL is a part of Bio-Pharm Competence Center for Biotechnology and Pharmaceuticals.
WHO: World is running out of antibiotics
On 20th September 2017, WHO launched report about antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, including tuberculosis. Report shows a